Last Week in Biomedicine — every Tuesday. Ten of the week's most significant biopharma stories: Phase 2 and Phase 3 trial readouts, breakthrough therapies, FDA updates, and the data driving drug development. For biotech investors, clinicians, researchers, and anyone following the next generation of medicine.